Beyond the CE Mark: A Call to Action for Minimum CGM Accuracy Standards in Central and Eastern European Nations

T.K.'s institution received a beneficiary from Medtronic and Ypsomed/MyLife. T.K. received consulting fees from Medtronic, Dexcom, Abbott, Eli Lilly, Novo Nordisk and Sanofi, and honoraria from Medtronic, Dexcom, Abbott, Eli Lilly, Novo Nordisk, Sanofi, Krka, Servier, Astra Zeneca and Boehringer Ingelheim. T.K. received support for attending meetings/travel from Novo Nordisk and Sanofi, participated on a data safety or advisory board for Medtronic, Eli Lilly, Novo Nordisk, Sanofi and Dexcom and has stock or stock options with Eli Lilly. A.I.'s institution received grants or grants from Boehringer Ingelheim, Pfizer, Sanaclis, Eli Lilly, Egis, KRKA, Servier, Abbott, Sanofi-Aventis, Novo Nordisk, Novartis and Bayer, consulting fees from Novo Nordisk, Novartis, Boehringer Ingelheim, Eli Lilly, Egis, Abbott and Sanofi-aventis and honoraria from Novo Nordisk, Novartis, Boehringer Ingelheim, Pfizer, Eli Lilly, Egis, KRKA, Servier, Abbott and Sanofi-aventis. A.I. is the president of the Slovak Diabetes Society (unpaid) and is part of the Categorization Committee for Medical Devices Ministry of Health. A.J. has received consulting fees from Novo Nordisk and Roche and honoraria from Novo Nordisk, Eli Lilly, Medtronic, Sibionics, Astra Zeneca, Boehringer Ingelheim, Sanofi-aventis, KRKA and Roche. S.K. received honoraria from Abbott, Astra Zeneca, Berlin, Chemie, Boehringer Ingelheim, Eli Lilly, Novartis, Novo Nordisk, Medtronic, Swixx Biopharma, support for attending meetings from Abbott, Eli Lilly, Novo Nordisk and Swixx Biopharma and participated on a data safety or advisory board for Abbott, Boehringer Ingelheim, Eli Lilly and Novo Nordisk. M.K. received honoraria from Abbott, MedilabOne (Dexcom), Roche, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Astra Zeneca, Fresenius, Sandoz, Novartis, Novatin, Swixx and Bio. M.K. received support for attending meetings from Abbott, MedilabOne (Dexcom), Roche, Novo Nordisk, Eli Lilly, Novatin and Swixx and participated on a data safety or advisory board for Abbott, Novo Nordisk, Eli Lilly, Astra Zeneca, Fresenius, Sandoz, Novartis and Biocon. P.N. received honoraria from Abbott, A-Import, Medtronic and Roche. M.P.'s institution received an institutional grant from Czech Health Research Council. M.P. received consulting fees from Abbott, Roche, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Astra Zeneca, Novartis, Novatin and Sanofi, honoraria from Abbott, Roche, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Astra Zeneca, Novartis, Novatin and Sanofi and support for attending meetings from Novo Nordisk, Astra Zeneca and Eli Lilly. M.P. has participated on a data safety or advisory board panel for Abbott, Novo Nordisk, Eli Lilly, Astra Zeneca and Sanofi and is the president of the Czech Diabetes Society. M.S. has received honoraria from Abbott, Dexcom/MedilabOne, Medtronic/Mediligo, Novo Nordisk, Pfizer, Sandoz, Swixx and Biomarin and support for attending meetings from Abbott, Dexcom/MedilabOne, Medtronic/Mediligo, Novo Nordisk, Pfizer, Sandoz and Biomarin. J.Š. received consulting fees from Abbott, Dexcom, Roche, Novo Nordisk, Eli Lilly, Astra Zeneca, Sanofi, honoraria from Abbott, Roche, Dexcom, Novo Nordisk, Eli Lilly, Astra Zeneca, Sanofi and support for attending meetings and/or travel from Novo Nordisk, Eli Lilly (ADA, ECO, EASD). J.Š. is the Vice-President for the Czech Diabetes Society and is a permanent member of the Commission for Categorization and Reimbursement Regulation of Medical Devices, Ministry of Health of the Czech Republic. A.S. has received speaker/constant fees from Amgen, Astra Zeneca, Boehringer Engelheim, Coco-Cola, Dexcom, Novo Nordisk, Novartis, Medtronic, Merck, MSD, Eli Lilly, Sandoz, Sanofi and Servier and has participated on advisory boards for Amgen, AstraZeneca, Boehringer Ingelheim, Merck, Medtronic, MSD, Novartis, Novo Nordisk, Roche Diabetes, Sandoz, Sanofi and Servier. T.T. received honoraria from Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Astra Zeneca, Medtronic and Merck, support for attending meetings from Novo Nordisk, Boehringer Ingelheim and Astra Zeneca and has participated on advisory boards for Novo Nordisk, Eli Lilly, Astra Zeneca, Boehringer Ingelheim and Medtronic. S.C.-V. received honoraria from Abbott, MedilabOne (Dexcom), Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Astra Zeneca, Fresenius, Sandoz, Teva and Biocon. S.C.-V. received support for attending meetings from Abbott, MedilabOne (Dexcom), Novo Nordisk and Eli Lilly and participated on a data safety or advisory board for Abbott, Novo Nordisk, Eli Lilly, Astra Zeneca, Fresenius, Sandoz, Pliva and Boehringer Ingelheim. T.B.'s institution received research grant support from Abbott, Medtronic, Novo Nordisk Sanofi, Novartis, Sandoz, SAB Bio, and Tandem, Slovenian Research and Innovation Agency, the National Institutes of Health, BreakthroughT1D, Helmsley Foundation and the European Union. T.B. received honoraria from Eli Lilly, Novo Nordisk, Medtronic, Abbott, Sanofi, Dexcom, Aventis, Astra Zeneca, Pfizer and Roche and participated on a data safety or advisory board for Novo Nordisk, Sanofi, Eli Lilly, Astra Zeneca, Medtronic, Abbott, Tandem and Roche. Data sharing not applicable to this article as no datasets were generated or analysed during the current study. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.71344.